Jackson Health System has resumed normal operations at a majority of its facilities.
The UHealth Jackson Urgent Care at Cutler Bay is now open
The UHealth Jackson Urgent Care center at Keystone Point is now open
The UHealth Jackson Urgent Care center at Country Walk is now open
The Jefferson Reaves remain closed due to power outages.
To reschedule an appointment, please call 305-585-6000. Updated information for UHealth Jackson Urgent Care centers is available at JacksonUrgentCare.com.
Neuroendovascular surgery is a relatively new subspecialty that has been evolving since the mid-1970s. Neuroendovascular surgery, a subspecialty within the fields of radiology and neurosurgery, is the management and treatment of complex neurologic lesions using minimally invasive techniques.
During the past two decades, significant advances have been made in the field of minimally invasive therapy for the treatment of intracranial cerebral aneurysms; acute stroke therapy intervention; cerebral arteriovenous malformations; carotid cavernous sinus fistulas; head, neck and spinal cord vascular lesions; and other complex cerebrovascular diseases.
One distinguishing factor about the neuroendovascular service at Jackson Memorial Hospital is that it is the only hospital in Miami-Dade with two neuroangiography suites, both of which are equipped with state-of-the-art technology and devices including:
- MERCI Clot Retriever
- PENUMBRA Stroke System
- GDC Coils
- ONYX Liquid Embolic
- X-act Carotid Stent
- Emboshield Carotid Protection Device
The suites also have three-dimensional imaging onsite at JMH and are led by two of the nation’s leading neurologists and neurosurgeons, Drs. Dileep R. Yavagal and Mohammad A. Aziz-Sultan. Additionally, the post operative stroke care unit and neurocritical care unit is equipped with 24 beds.
The neuroendovascular surgery department is also conducting several studies and clinical trials at Jackson Memorial Hospital. They are the following:
1. SENTIS – an industry-sponsored, prospective, controlled, randomized, single-blind, multi-center study comparing NeuroFlo Treatment plus standard medical management vs. standard medical management alone
2. IMS III (NIH-Sponsored Study) – a phase III, randomized, multi-center, open label, 900 subject clinical trial that will examine whether a combined intravenous (IV) and intra-arterial (IA) approach to recanalization is superior to standard IV rt-PA (Activase®) alone when initiated within three hours of acute ischemic stroke onset
3. SAMMPRIS – an NIH-sponsored multi-center trial for stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis
4. RACER – an industry-sponsored clinical trial to study the safety and effectiveness of coils for the treatment of intracranial aneurysms that cannot be treated by brain surgery or are high risk for brain surgery
5. CONSCIOUS 2 – an industry-sponsored prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping